Initial telehealth consultation with a US-licensed provider Provider follow-up and dose titration support Direct-to-home prescription shipping Visit:$50$129/visitInsurance acceptedAvailable:Most US states Trust Score: B US-licensed cliniciansHIPAA-compliantUpdated this week GLP-1 from $50 $129/visit + meds #2TOP RATED MEDVi 4.71,760 verified reviews Flat-rate GLP-1 telehealth with the strongest balance of cost, care, and provider access
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Bellido D., Abelln P., Ruiz Palomar J.M., lvarez Sintes R., Nubiolae A., Bellido V., Romero G., Basal Lixi Study investigators Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
The FDA-approved dosing regimen is specifically designed to allow gradual physiologic adaptation, and adherence to this schedule typically results in shorter symptom duration
In the meantime, patients can explore existing weight loss medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro)
Get to your weight goals naturally without side effects and large expense
PMCID: PMC8978023
